DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ch97m9/glycobiologyglyco) has announced the addition of the "Glycobiology/Glycomics Market by Product, Application & by End User - Global Forecast to 2019" report to their offering.
The global glycomics market was valued at $512.38 million in 2014, and is expected to grow at a CAGR of 12.62% to reach $928.11 million in 2019.
Glycobiology enzymes, instruments, kits, & reagents find applications in a large number of fields in life science research, as well as diagnostics and drug discovery research. Glycomics products are widely used for the analysis of cell surface markers, which can act as diagnostic or therapeutic targets. Being one of the most widely used applications of glycomics, drug discovery and development was one of the largest application segments of the global glycomics market in 2014. Glycobiology products are often used in the investigation of the role of glycansin in the development of cancer, Alzheimer's, Parkinson's, and infectious diseases like herpes and AIDS.
The report provides a granular understanding of the glycomics enzymes, instruments, kits and reagents market. This report segments the global glycomics market on the basis of applications, end users, products and geographies. The application segments included in this report are diagnostics; drug discovery and development; immunology; oncology; and other applications. The end-user segments of this market are academic research institutes, contract research organizations, and pharmaceutical and biotechnology companies.
The product segments included in this report are enzymes, instruments, kits, and reagents. The subsegments of the enzymes product segment included in this report are glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes. The subsegments of the instruments product segment included in this report are antibody arrays; HPLC; lectin arrays; MALDI-TOF; mass spectrometry; and other instruments. The subsegments of the kits product segment included in this report are glycan labeling kits; glycan purification kits; glycan release kits; and other kits. The subsegments of the reagents product segment included in this report are glycoproteins; monosaccharides; oligosaccharides; and other reagents.
The major players in the glycomics enzymes, instruments, kits and reagents market include:
- Agilent Technologies, Inc.
- Bruker Corporation
- Danaher Corporation
- New England Biolabs
- Shimadzu Corporation
- Sigma-Aldrich Corporation
- Takara Bio
- Thermo Fisher Scientific
- Waters Corporation
For more information visit http://www.researchandmarkets.com/research/ch97m9/glycobiologyglyco.